Wordt geladen...
Severe thrombocytopenia after trastuzumab retreatment: a case report
BACKGROUND: Trastuzumab prolongs survival of human epidermal growth factor receptor 2-positive breast cancer patients in both the adjuvant and metastatic settings. Currently toxicity data are not available on retreatment of metastatic breast cancer patients who relapse after adjuvant trastuzumab. We...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3851485/ https://ncbi.nlm.nih.gov/pubmed/24093447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-6-400 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|